Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Operating Expenses | 9,720 | 5,740 | 8,290 | 7,960 | 7,980 |
| Operating Income | -9,720 | -5,740 | -8,290 | -7,960 | -7,980 |
| Interest Expense | 0 | -50 | 50 | 0 | 0 |
| Other Income | -1,530 | -1,140 | 1,320 | -1,580 | 8,240 |
| Pre-tax Income | -11,250 | -6,830 | -7,020 | -9,540 | 260 |
| Net Income Continuous | -11,250 | -6,802 | -7,028 | -9,538 | 261 |
| Net Income | $-11,250 | $-6,802 | $-7,028 | $-9,538 | $261 |
| EPS Basic Total Ops | -0.49 | -0.29 | -0.30 | -0.41 | 0.01 |
| EPS Basic Continuous Ops | -0.48 | -0.29 | -0.30 | -0.41 | 0.01 |
| EPS Diluted Total Ops | -0.49 | -0.29 | -0.30 | -0.41 | 0.01 |
| EPS Diluted Continuous Ops | -0.48 | -0.29 | -0.30 | -0.41 | 0.01 |
| EBITDA(a) | $-9,352 | $-5,580 | $-8,040 | $-7,940 | $-7,880 |